The purpose of this study was to investigate whether patients undergoing primary shoulder arthroplasty with opioid use disorder have higher rates of (1) implant-related complications; (2) in-hospital lengths of stay; (3) readmission rates; and (4) costs of care.
Methods
Opioid use disorder patients undergoing primary shoulder arthroplasty were queried and matched in a 1:5 ratio to controls by age, sex, and medical comorbidities within the Medicare database. The query yielded 25,489 patients with (n = 4253) and without (n = 21,236) opioid use disorder. Primary outcomes analyzed included: 2-year implant related complications, in-hospital lengths of stay, 90-day readmission rates, and 90-day costs of care. A p value less than 0.01 was considered statistically significant.
Results
Opioid use disorder patients had significantly longer in-hospital lengths of stay (3 days vs. 2 days; p < 0.0001) compared to matched controls. Opioid use disorder patients were also found to have higher incidence and odds (OR) of readmission rates (12.84 vs. 7.45%; OR: 1.16, p < 0.0001) and implant-related complications (20.03 vs. 7.95%; OR: 1.82, p < 0.0001). Study group patients also incurred significantly higher 90-day costs of care ($16,918.85 vs. $15,195.37, p < 0.0001).
Discussion
This study can be used to help further augment efforts to reduce opioid prescriptions from healthcare providers in shoulder arthroplasty settings.
KimSHWiseBLZhangY, et al.Increasing incidence of shoulder arthroplasty in the United States. J Bone Joint Surg Am2011; 93: 2249–2254.
2.
SivasundaramLHeckmannNPannellWC, et al.Preoperative risk factors for discharge to a postacute care facility after shoulder arthroplasty. J Shoulder Elbow Surg2016; 25: 201–206.
3.
DayJSLauEOngKL, et al.Prevalence and projections of total shoulder and elbow arthroplasty in the United States to 2015. J Shoulder Elbow Surg2010; 19: 1115–1120.
4.
MorrisBJMirHR. The opioid epidemic: impact on orthopaedic surgery. J Am Acad Orthop Surg2015; 23: 267–271.
5.
MorrisBJSciasciaADJacobsCA, et al.Preoperative opioid use associated with worse outcomes after anatomic shoulder arthroplasty. J Shoulder Elbow Surg2016; 25: 619–623.
6.
SabesanVJPetersen-FittsGRSweetMC, et al.The impact of preoperative opioid use on outcomes after arthroscopic rotator cuff repair. JSES Open Access2018; 2: 155–158.
7.
Saxon A, Renner J, Greenfield S, et al. Opioid use disorder. psychiatry.org. American Psychiatric Association.
8.
VakhariaRMSabehKGCohen-LevyWB, et al.Opioid disorders are associated with thromboemboli following primary total knee arthroplasty. J Arthroplasty2019; 34: 2957–2961.
9.
BaldiniAVon KorffMLinEHB. A review of potential adverse effects of long-term opioid therapy. Prim Care Companion CNS Disord2012; 14: PCC.11m01326–PCC.11m01326.
10.
DunnKMSaundersKWRutterCM, et al.Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med2010; 152: 85–92.
11.
BellTJPanchalSJMiaskowskiC, et al.The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med2009; 10: 35–42.
12.
CarmanWJSuSCookSF, et al.Coronary heart disease outcomes among chronic opioid and cyclooxygenase-2 users compared with a general population cohort. Pharmacoepidemiol Drug Saf2011; 20: 754–762.
13.
LerouxTSSaltzmanBMSumnerSA, et al.Elective shoulder surgery in the opioid naïve: rates of and risk factors for long-term postoperative opioid use. Am J Sports Med2019; 47: 1051–1056.
14.
HalawiMJVovosTJGreenCL, et al.Opioid-based analgesia: impact on total joint arthroplasty. J Arthroplasty2015; 30: 2360–2363.
15.
CancienneJMBrockmeierSFCarsonEW, et al.Risk factors for infection after shoulder arthroscopy in a large medicare population. Am J Sports Med2018; 46: 809–814.
16.
NiedzielakTRAmeriBJEmersonB, et al.Trends in cervical disc arthroplasty and revisions in the Medicare database. J Spine Surg2018; 4: 522–528.
17.
VakhariaRMSabehKGSodhiN, et al.Implant-related complications among patients with opioid use disorder following primary total hip arthroplasty: a matched-control analysis of 42,097 Medicare patients. J Arthroplasty2020; 35: 178–181.
18.
SaundersKWDunnKMMerrillJO, et al.Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med2010; 25: 310–315.
19.
TakkoucheBMontes-MartínezAGillSS, et al.Psychotropic medications and the risk of fracture: a meta-analysis. Drug Saf2007; 30: 171–184.
20.
MillerMStürmerTAzraelD, et al.Opioid analgesics and the risk of fractures in older adults with arthritis. J Am Geriatr Soc2011; 59: 430–438.
21.
SingDCBarryJJCheahJW, et al.Long-acting opioid use independently predicts perioperative complication in total joint arthroplasty. J Arthroplasty2016; 31: 170–174.e1.
22.
MintzerMZLanierRKLofwallMR, et al.Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers. Drug Alcohol Depend2010; 111: 265–268.
23.
MattiaCDi BussoloEColuzziF. Non-analgesic effects of opioids: the interaction of opioids with bone and joints. Curr Pharm Des2012; 18: 6005–6009.
24.
Pérez-CastrillónJLOlmosJMGómezJJ, et al.Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells. Neuroendocrinology2000; 72: 187–194.
25.
DaniellHW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain2008; 9: 28–36.
26.
ImaiYKondohSKouzmenkoA, et al.Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-α. Mol Endocrinol2010; 24: 877–885.
27.
BellKLShohatNGoswamiK, et al.Preoperative opioids increase the risk of periprosthetic joint infection after total joint arthroplasty. J Arthroplasty2018; 33: 3246–3251.e1.
28.
EisensteinTKRahimRTFengP, et al.Effects of opioid tolerance and withdrawal on the immune system. J Neuroimmune Pharmacol2006; 1: 237–249.
29.
WangXZhangTHoWZ. Opioids and HIV/HCV infection. J Neuroimmune Pharmacol2011; 6: 477–489.
30.
LiangXLiuRChenC, et al.Opioid system modulates the immune function: a review. Transl Perioper Pain Med2016; 1: 5–13.
31.
BayerBMDaussinSHernandezM, et al.Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology1990; 29: 369–374.
SingDCBarryJJCheahJW, et al.Long-acting opioid use independently predicts perioperative complication in total joint arthroplasty. J Arthroplasty2016; 31: 170–174.e1.
34.
MenendezMERingDBatemanBT. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res2015; 473: 2402–2412.
35.
CheahJWSingDCMcLaughlinD, et al.The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes. J Shoulder Elbow Surg2017; 26: 1908–1914.
36.
GuptaANizamuddinJElmoftyD, et al.Opioid abuse or dependence increases 30-day readmission rates after major operating room procedures. Anesthesiology2018; 128: 880–890.
37.
JainNPhillipsFMWeaverT, et al.Preoperative chronic opioid therapy: a risk factor for complications, readmission, continued opioid use and increased costs after one- and two-level posterior lumbar fusion. Spine2018; 43: 1331–1338.
38.
MeyerRPatelAMRattanaSK, et al.Prescription opioid abuse: a literature review of the clinical and economic burden in the United States. Popul Health Manage2014; 17: 372–387.
39.
BirnbaumHGWhiteAGSchillerM, et al.Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med2011; 12: 657–667.
40.
ChangHYKharraziHBodycombeD, et al.Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Med2018; 16: 69–69.
